Norges Bank Buys New Position in Corteva, Inc. $CTVA

Posted by on Jun 1st, 2026

Norges Bank bought a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 7,519,031 shares of the company’s stock, valued at approximately $504,001,000. Norges Bank owned 1.11% of Corteva at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter valued at about $25,000. Redmont Wealth Advisors LLC bought a new stake in Corteva during the third quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. grew its holdings in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares during the period. Basepoint Wealth LLC bought a new stake in Corteva during the fourth quarter valued at about $30,000. Finally, KERR FINANCIAL PLANNING Corp bought a new stake in Corteva during the third quarter valued at about $33,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

NYSE CTVA opened at $78.41 on Monday. The firm has a market cap of $52.44 billion, a price-to-earnings ratio of 46.12, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The business has a 50-day moving average price of $81.33 and a 200-day moving average price of $74.60. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63.

Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Analysts Set New Price Targets

CTVA has been the subject of several recent research reports. Berenberg Bank boosted their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. The Goldman Sachs Group upped their price target on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Jefferies Financial Group upped their price target on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Royal Bank Of Canada upped their price target on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Finally, Rothschild & Co Redburn upped their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.

Check Out Our Latest Stock Analysis on CTVA

Corteva Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.